Form 4: GE HealthCare GC Awarded Equity, Options

GE HealthCare Technologies Inc.'s General Counsel, Frank R. Jimenez, was granted 10,915 restricted stock units and 28,697 employee stock options.

Summary

• Frank R. Jimenez, General Counsel and Corporate Secretary of GE HealthCare Technologies Inc., was awarded 10,915 shares of common stock in the form of restricted stock units (RSUs) on March 2, 2026.
• Each RSU represents the right to receive one share of GE HealthCare common stock, with no acquisition price.
• The RSUs will vest in three tranches: 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029.
• Additionally, Mr. Jimenez was awarded 28,697 employee stock options on March 2, 2026, with an exercise price of $80.16 per share.
• These stock options will become exercisable in three tranches: 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029.
• The employee stock options have an expiration date of March 2, 2036.
• Following these transactions, Mr. Jimenez beneficially owns 92,182 shares of common stock and 28,697 derivative securities (employee stock options).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development for corporate governance, as it aligns the General Counsel's interests with long-term shareholder value through equity incentives, though it is a routine disclosure.

Positives

• The equity awards align the interests of a key executive, Frank R. Jimenez, with those of long-term shareholders, incentivizing sustained company performance.
• The grant of restricted stock units and stock options is a standard component of executive compensation, aimed at retaining talent and motivating performance.

Industry Context

StockSavvy.ai notes that equity awards, such as restricted stock units and stock options, are a standard component of executive compensation packages across the healthcare technology sector. These incentives are designed to align the long-term interests of executives with shareholder value and to aid in talent retention within competitive industries.

Comparison to Industry Standards

• The structure of these equity awards, including the multi-year vesting schedule, is consistent with common practices for executive compensation in large-cap companies within the healthcare technology industry, such as Siemens Healthineers AG or Philips N.V., which also utilize performance-based equity to incentivize leadership.
• The grant of options with an exercise price at or above the market price on the grant date (implied by the $0 acquisition price for the award itself, but $80.16 exercise price for the option) is a typical approach to ensure executives benefit from future stock price appreciation.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential positive impact through enhanced alignment of executive interests with long-term company performance and shareholder value creation.
• Employees: No direct impact on the broader employee base, but reflects standard executive compensation practices.

Next Steps

• The restricted stock units will vest in tranches on September 2, 2027, September 2, 2028, and September 2, 2029.
• The employee stock options will become exercisable in tranches on September 2, 2027, September 2, 2028, and September 2, 2029.

Key Dates

Recommendation

This Form 4 details a routine equity award to a key executive, which is a positive for aligning management incentives with shareholder interests. However, it does not provide new fundamental information to warrant a change in investment recommendation based solely on this filing, thus maintaining a 'hold' stance.

Keywords

GE HealthCare, GEHC, Frank R. Jimenez, Form 4, Insider Transaction, Equity Award, Restricted Stock Units, Stock Options, Executive Compensation, Corporate Governance